Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01936974
Title (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Western Regional Medical Center
Indications

peritoneal carcinoma

ovarian carcinoma

fallopian tube carcinoma

Therapies

Bevacizumab + Cisplatin + Gemcitabine

Bevacizumab + Gemcitabine + Oxaliplatin

Bevacizumab + Carboplatin + Gemcitabine

Bevacizumab + Gemcitabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.